Market open
GH Research/$GHRS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GH Research
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Ticker
$GHRS
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Dublin, Ireland
Employees
50
ISIN
IE000GID8VI0
Website
GH Research Metrics
BasicAdvanced
$664M
-
-$0.79
0.86
-
Price and volume
Market cap
$664M
Beta
0.86
52-week high
$20.50
52-week low
$6.00
Average daily volume
163K
Financial strength
Current ratio
29.71
Quick ratio
29.376
Long term debt to equity
0.104
Total debt to equity
0.212
Interest coverage (TTM)
-71.95%
Management effectiveness
Return on assets (TTM)
-11.97%
Return on equity (TTM)
-16.20%
Valuation
Price to book
1.96
Price to tangible book (TTM)
1.96
Price to free cash flow (TTM)
-13.854
Growth
Earnings per share change (TTM)
26.76%
3-year earnings per share growth (CAGR)
40.91%
What the Analysts think about GH Research
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for GH Research stock.
GH Research Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
GH Research Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
GH Research News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GH Research stock?
GH Research (GHRS) has a market cap of $664M as of May 16, 2025.
What is the P/E ratio for GH Research stock?
The price to earnings (P/E) ratio for GH Research (GHRS) stock is 0 as of May 16, 2025.
Does GH Research stock pay dividends?
No, GH Research (GHRS) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next GH Research dividend payment date?
GH Research (GHRS) stock does not pay dividends to its shareholders.
What is the beta indicator for GH Research?
GH Research (GHRS) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.